Head-to-head · WeighScore
Henry Meds vs NEUVÉ Health
The verdict
Henry Meds takes it — 77.3/100 to 64.7/100.
Henry Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Henry's low monthly equivalents come with a full year paid upfront, so it is a poor fit for someone shopping for a short trial.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Henry Meds | NEUVÉ Health |
|---|---|---|
| WeighScore | 77.3/100 | 64.7/100 |
| Grade | C+ | C |
| Scorecard rank | #48 | #254 |
| Semaglutide | $197/mo (injectable; 12-month plan paid upfront in full, $2,364) | $179/mo (injectable microdose with B12; the site gives three answers on whether medication is included) |
| Tirzepatide | $234/mo (compounded oral tablets; 12-month plan paid upfront in full, $2,808) | $240/mo (injectable microdose with B12; the site gives three answers on whether medication is included) |
| Coverage | Multi-state | All 50 states (claimed; the same page says members in 40+ states) |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Yes |
Graded #48 · C+
Strengths
- Published plan prices identify their upfront-payment requirement
- Medication, provider access, applicable supplies and shipping included if prescribed
- Compounded injectable semaglutide and oral options listed
Where it loses points
- The $197 semaglutide headline requires $2,364 upfront, not monthly payments
- The listed $234 tirzepatide offer is oral compounded medication, not an injectable quote
- Multi-month balances may remain payable after cancellation; medical-discontinuation refunds require documentation and approval, and dispensed medication is excluded
Graded #254 · C
Strengths
- The whole GLP-1 catalog is built around microdosing rather than offering it as an afterthought, with an injectable and a daily sublingual route at different prices
- Names its lab partners, Quest and LabCorp, and says panel pricing is confirmed before a charge
- States both compounding classes on the homepage rather than leaving the question open
- Names clinicians on the site and inside the matching step of the intake
- A large hormone, peptide and lab menu sits beside the GLP-1 lines
Where it loses points
- Three incompatible answers to whether medication is in the price: the weight-loss program page is headed “all-in monthly pricing” and its own fine print says medication, labs and supplies are billed separately
- Four different “from” floors are published across four pages, one of which belongs to the testosterone line rather than the GLP-1 one
- Three membership tiers — Core, Plus and Premium — are named once in the financial policy and priced nowhere
- The tirzepatide sublingual microdose card lists compounded sublingual semaglutide microdose in its own inclusion list
- Every legal page closes by saying it is plain-English summary copy under review by counsel and may change before public launch, on a site already taking intake
- “All 50 U.S. states” and “members in 40+ states” are printed on the same homepage without the distinction the About page draws
- Membership fees are non-refundable, and no pharmacy, medical group entity or NPI is named
Also worth a look
Another provider to compare: CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.